Karius
About:
Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.
Website: https://kariusdx.com
Twitter/X: kariusdx
Top Investors: Khosla Ventures, General Catalyst, Lightspeed Venture Partners, Tencent, Seventure Partners
Description:
Karius is a life sciences company focused on generating genomic insights for infectious diseases with a liquid biopsy for infectious diseases. The Karius Test that helps clinicians make rapid, treatment decisions. By mapping each patient’s microbial landscape from a single blood draw, Karius moves closer to a vision of a world where infectious disease is no longer a major threat to human health. The Karius laboratory is CLIA-certified and CAP-accredited to perform high-complexity clinical laboratory testing.
$354M
$1M to $10M
Redwood City, California, United States
2014-01-01
media(AT)kariusdx.com
Emerging Unicorn
Mickey Kertesz, Steve Quake, Tim Blauwkamp
101-250
2024-05-02
Private
© 2025 bioDAO.ai